Log in

OTCMKTS:PARNF - Parnell Pharmaceuticals Stock Price, Forecast & News

0.00 (0.00 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
Now: $0.10
50-Day Range
MA: $0.12
52-Week Range
Now: $0.10
Average Volume1,470 shs
Market Capitalization$1.84 million
P/E RatioN/A
Dividend YieldN/A
Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal — U.S., Production Animal — Rest of World, and Contract Manufacturing. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for breeding programs in dairy and beef cows; and Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product aids in the treatment of OA for dogs, as well as Reviderm, an anti-microbial liquid bandage for use in companion animals. The company is also developing various products, such as PAR121 for bone-related diseases and injuries in dogs, cats, and horses; and PAR122 for atopic dermatitis and other dermatological conditions, as well as PROCEPT, a next generation breeding program. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Previous SymbolNASDAQ:PARN



Sales & Book Value

Annual Sales$14.67 million



Market Cap$1.84 million
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable

Receive PARNF News and Ratings via Email

Sign-up to receive the latest news and ratings for PARNF and its competitors with MarketBeat's FREE daily newsletter.

Parnell Pharmaceuticals (OTCMKTS:PARNF) Frequently Asked Questions

What is Parnell Pharmaceuticals' stock symbol?

Parnell Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PARNF."

When is Parnell Pharmaceuticals' next earnings date?

Parnell Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Friday, April 3rd 2020. View Earnings Estimates for Parnell Pharmaceuticals.

Has Parnell Pharmaceuticals been receiving favorable news coverage?

Headlines about PARNF stock have been trending somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Parnell Pharmaceuticals earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Parnell Pharmaceuticals.

Who are some of Parnell Pharmaceuticals' key competitors?

What other stocks do shareholders of Parnell Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Parnell Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Esperion Therapeutics (ESPR), MEI Pharma (MEIP), Zafgen (ZFGN), Actinium Pharmaceuticals (ATNM), Achaogen (AKAO), Akebia Therapeutics (AKBA), Aurinia Pharmaceuticals (AUPH), Bellerophon Therapeutics (BLPH) and Celgene (CELG).

Who are Parnell Pharmaceuticals' key executives?

Parnell Pharmaceuticals' management team includes the folowing people:
  • Dr. Alan Richard Bell, Exec. Chairman (Age 63)
  • Mr. Brad R. McCarthy, CEO, CFO, Chief Accounting Officer & Exec. Director (Age 43)

How do I buy shares of Parnell Pharmaceuticals?

Shares of PARNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Parnell Pharmaceuticals' stock price today?

One share of PARNF stock can currently be purchased for approximately $0.10.

How big of a company is Parnell Pharmaceuticals?

Parnell Pharmaceuticals has a market capitalization of $1.84 million and generates $14.67 million in revenue each year. View Additional Information About Parnell Pharmaceuticals.

What is Parnell Pharmaceuticals' official website?

The official website for Parnell Pharmaceuticals is http://www.parnell.com/.

How can I contact Parnell Pharmaceuticals?

Parnell Pharmaceuticals' mailing address is UNIT 4 CENTURY ESTATE 476 GARDENERS ROAD, ALEXANDRIA C3, 2015. The company can be reached via phone at 61-2-9667-4411 or via email at [email protected]

MarketBeat Community Rating for Parnell Pharmaceuticals (OTCMKTS PARNF)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  109 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  202
MarketBeat's community ratings are surveys of what our community members think about Parnell Pharmaceuticals and other stocks. Vote "Outperform" if you believe PARNF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PARNF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel